Literature DB >> 23842751

Functional redundancy of MyD88-dependent signaling pathways in a murine model of histidyl-transfer RNA synthetase-induced myositis.

Irina Fernandez1, Lisa Harlow, Yunjuan Zang, Ru Liu-Bryan, William M Ridgway, Paula R Clemens, Dana P Ascherman.   

Abstract

We have previously shown that i.m. administration of bacterially expressed murine histidyl-tRNA synthetase (HRS) triggers florid muscle inflammation (relative to appropriate control proteins) in various congenic strains of mice. Because severe disease develops even in the absence of adaptive immune responses to HRS, we sought to identify innate immune signaling components contributing to our model of HRS-induced myositis. In vitro stimulation assays demonstrated HRS-mediated activation of HEK293 cells transfected with either TLR2 or TLR4, revealing an excitatory capacity exceeding that of other bacterially expressed fusion proteins. Corresponding to this apparent functional redundancy of TLR signaling pathways, HRS immunization of B6.TLR2(-/-) and B6.TLR4(-/-) single-knockout mice yielded significant lymphocytic infiltration of muscle tissue comparable to that produced in C57BL/6 wild-type mice. In contrast, concomitant elimination of TLR2 and TLR4 signaling in B6.TLR2(-/-).TLR4(-/-) double-knockout mice markedly reduced the severity of HRS-induced muscle inflammation. Complementary subfragment analysis demonstrated that aa 60-90 of HRS were absolutely required for in vitro as well as in vivo signaling via these MyD88-dependent TLR pathways--effects mediated, in part, through preferential binding of exogenous ligands capable of activating specific TLRs. Collectively, these experiments indicate that multiple MyD88-dependent signaling cascades contribute to this model of HRS-induced myositis, underscoring the antigenic versatility of HRS and confirming the importance of innate immunity in this system.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23842751      PMCID: PMC4332536          DOI: 10.4049/jimmunol.1203070

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  31 in total

1.  Two distinct cytokines released from a human aminoacyl-tRNA synthetase.

Authors:  K Wakasugi; P Schimmel
Journal:  Science       Date:  1999-04-02       Impact factor: 47.728

2.  Down-regulation of the aberrant expression of the inflammation mediator high mobility group box chromosomal protein 1 in muscle tissue of patients with polymyositis and dermatomyositis treated with corticosteroids.

Authors:  Ann-Kristin Ulfgren; Cecilia Grundtman; Kristian Borg; Helene Alexanderson; Ulf Andersson; Helena Erlandsson Harris; Ingrid E Lundberg
Journal:  Arthritis Rheum       Date:  2004-05

3.  Multiple Toll-like receptor ligands induce an IL-6 transcriptional response in skeletal myocytes.

Authors:  Robert A Frost; Gerald J Nystrom; Charles H Lang
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2005-10-27       Impact factor: 3.619

4.  TLR4 as receptor for HMGB1 induced muscle dysfunction in myositis.

Authors:  Mei Zong; Joseph D Bruton; Cecilia Grundtman; Huan Yang; Jian Hua Li; Helene Alexanderson; Karin Palmblad; Ulf Andersson; Helena E Harris; Ingrid E Lundberg; Håkan Westerblad
Journal:  Ann Rheum Dis       Date:  2012-11-12       Impact factor: 19.103

5.  Toll-like receptors differentially regulate CC and CXC chemokines in skeletal muscle via NF-kappaB and calcineurin.

Authors:  John H Boyd; Maziar Divangahi; Linda Yahiaoui; Dusanka Gvozdic; Salman Qureshi; Basil J Petrof
Journal:  Infect Immun       Date:  2006-09-18       Impact factor: 3.441

Review 6.  Myositis specific autoantibodies.

Authors:  Ira N Targoff
Journal:  Curr Rheumatol Rep       Date:  2006-06       Impact factor: 4.592

7.  A possible mechanism for endogenous activation of the type I interferon system in myositis patients with anti-Jo-1 or anti-Ro 52/anti-Ro 60 autoantibodies.

Authors:  Maija-Leena Eloranta; Sevim Barbasso Helmers; Ann-Kristin Ulfgren; Lars Rönnblom; Gunnar V Alm; Ingrid E Lundberg
Journal:  Arthritis Rheum       Date:  2007-09

8.  Species-specific immune responses generated by histidyl-tRNA synthetase immunization are associated with muscle and lung inflammation.

Authors:  Yasuhiro Katsumata; William M Ridgway; Timothy Oriss; Xinyan Gu; David Chin; Yuehong Wu; Noreen Fertig; Tim Oury; Daniel Vandersteen; Paula Clemens; Carlos J Camacho; Andrew Weinberg; Dana P Ascherman
Journal:  J Autoimmun       Date:  2007 Sep-Nov       Impact factor: 7.094

Review 9.  Mechanisms of disease: autoantigens as clues to the pathogenesis of myositis.

Authors:  Tomeka L Suber; Livia Casciola-Rosen; Antony Rosen
Journal:  Nat Clin Pract Rheumatol       Date:  2008-03-04

10.  Histidyl-tRNA synthetase and asparaginyl-tRNA synthetase, autoantigens in myositis, activate chemokine receptors on T lymphocytes and immature dendritic cells.

Authors:  O M Zack Howard; Hui Fang Dong; De Yang; Nina Raben; Kanneboyina Nagaraju; Antony Rosen; Livia Casciola-Rosen; Michael Härtlein; Michael Kron; David Yang; Kwabena Yiadom; Sunita Dwivedi; Paul H Plotz; Joost J Oppenheim
Journal:  J Exp Med       Date:  2002-09-16       Impact factor: 14.307

View more
  2 in total

Review 1.  Role of Jo-1 in the Immunopathogenesis of the Anti-synthetase Syndrome.

Authors:  Dana P Ascherman
Journal:  Curr Rheumatol Rep       Date:  2015-09       Impact factor: 4.592

2.  TLR expression in peripheral monocyte subsets of patients with idiopathic inflammatory myopathies: association with clinical and immunological features.

Authors:  Jiram Torres-Ruiz; Daniel Alberto Carrillo-Vazquez; Diana Marcela Padilla-Ortiz; Ricardo Vazquez-Rodriguez; Carlos Nuñez-Alvarez; Guillermo Juarez-Vega; Diana Gomez-Martin
Journal:  J Transl Med       Date:  2020-03-12       Impact factor: 5.531

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.